Ralf Kuriyel

Track

Insider profile

Currently holds a position at Repligen Corp

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 61% 68% 82%
Transactions
28 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President - Research and Development Repligen Corp Oct. 1, 2016 -
Ralf Kuriyel's trades of Repligen Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Repligen Corp (RGEN)
Transaction date
Sale
Price
126.66
Quantity 86,765 -6.5%
Value US$2,621,764
US Repligen Corp (RGEN)
Transaction date
Sale
Price
186.80
Quantity 60,625 -23.2%
Value US$4,863,921
US Repligen Corp (RGEN)
Transaction date
Proposed sale
Price
54.25
Quantity 65,004
Value US$2,525,973
US Repligen Corp (RGEN)
Transaction date
Proposed sale
Price
165.67
Quantity 4,465
Value US$739,705
US Repligen Corp (RGEN)
Transaction date
Sale
Price
165.67
Quantity 4,465 -18.8%
Value US$739,717
US Repligen Corp (RGEN)
Transaction date
Sale
Price
193.73
Quantity 3,517 -12.7%
Value US$681,348
US Repligen Corp (RGEN)
Transaction date
Proposed sale
Price
193.73
Quantity 3,517
Value US$681,348
US Repligen Corp (RGEN)
Transaction date
Sale
Price
254.14
Quantity 4,040 -17.3%
Value US$1,026,726
US Repligen Corp (RGEN)
Transaction date
Sale
Price
255.20
Quantity 800 -3.3%
Value US$204,160
US Repligen Corp (RGEN)
Transaction date
Sale
Price
189.19
Quantity 6,802 -24.2%
Value US$1,286,870
US Repligen Corp (RGEN)
Transaction date
Sale
Price
172.29
Quantity 710 -2.8%
Value US$122,326
US Repligen Corp (RGEN)
Transaction date
Sale
Price
192.13
Quantity 1,004 -3.8%
Value US$192,899
US Repligen Corp (RGEN)
Transaction date
Sale
Price
191.33
Quantity 642 -2.4%
Value US$122,834
US Repligen Corp (RGEN)
Transaction date
Sale
Price
190.08
Quantity 6,354 -19.1%
Value US$1,207,768
US Repligen Corp (RGEN)
Transaction date
Sale
Price
190.06
Quantity 700 -2.7%
Value US$133,042
US Repligen Corp (RGEN)
Transaction date
Sale
Price
191.20
Quantity 600 -2.3%
Value US$114,720
US Repligen Corp (RGEN)
Transaction date
Sale
Price
192.24
Quantity 350 -1.3%
Value US$67,284
US Repligen Corp (RGEN)
Transaction date
Sale
Price
194.30
Quantity 25 -0.1%
Value US$4,858
US Repligen Corp (RGEN)
Transaction date
Sale
Price
196.23
Quantity 400 -1.5%
Value US$78,492
US Repligen Corp (RGEN)
Transaction date
Sale
Price
186.18
Quantity 435 -1.7%
Value US$80,988
US Repligen Corp (RGEN)
Transaction date
Sale
Price
153.79
Quantity 5,000 -16.1%
Value US$768,950
US Repligen Corp (RGEN)
Transaction date
Sale
Price
140.69
Quantity 435 -1.6%
Value US$61,200
US Repligen Corp (RGEN)
Transaction date
Sale
Price
128.55
Quantity 95 -0.4%
Value US$12,212
US Repligen Corp (RGEN)
Transaction date
Sale
Price
128.02
Quantity 6,293 -19.1%
Value US$805,630
US Repligen Corp (RGEN)
Transaction date
Sale
Price
126.88
Quantity 1,612 -4.7%
Value US$204,531
US Repligen Corp (RGEN)
Transaction date
Sale
Price
90.99
Quantity 1,905 -6.7%
Value US$173,336
US Repligen Corp (RGEN)
Transaction date
Sale
Price
90.08
Quantity 650 -2.2%
Value US$58,552
US Repligen Corp (RGEN)
Transaction date
Sale
Price
88.35
Quantity 450 -1.5%
Value US$39,758
US Repligen Corp (RGEN)
Transaction date
Sale
Price
86.60
Quantity 195 -0.7%
Value US$16,887
US Repligen Corp (RGEN)
Transaction date
Sale
Price
58.53
Quantity 2,240 -10.6%
Value US$131,107
US Repligen Corp (RGEN)
Transaction date
Sale
Price
59.16
Quantity 185 -1.1%
Value US$10,945
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-05 2024-08-02
US Repligen Corp (RGEN)
S Sale
86,765 -6.5%
126.66
US$2,621,764 		86,765 -6.5% 126.66 US$2,621,764
2024-08-05 2024-08-02
US Repligen Corp (RGEN)
S Sale
60,625 -23.2%
186.80
US$4,863,921 		60,625 -23.2% 186.80 US$4,863,921
2024-08-02 2024-08-02
US Repligen Corp (RGEN)
PrS Proposed sale
65,004
54.25
US$2,525,973 		65,004 54.25 US$2,525,973
2024-08-01 2024-08-01
US Repligen Corp (RGEN)
PrS Proposed sale
4,465
165.67
US$739,705 		4,465 165.67 US$739,705
2024-08-01 2024-08-01
US Repligen Corp (RGEN)
S Sale
4,465 -18.8%
165.67
US$739,717 		4,465 -18.8% 165.67 US$739,717
2024-03-12 2024-03-11
US Repligen Corp (RGEN)
S Sale
3,517 -12.7%
193.73
US$681,348 		3,517 -12.7% 193.73 US$681,348
2024-03-11 2024-03-11
US Repligen Corp (RGEN)
PrS Proposed sale
3,517
193.73
US$681,348 		3,517 193.73 US$681,348
2022-08-12 2022-08-11
US Repligen Corp (RGEN)
S Sale
4,040 -17.3%
254.14
US$1,026,726 		4,040 -17.3% 254.14 US$1,026,726
2022-08-12 2022-08-11
US Repligen Corp (RGEN)
S Sale
800 -3.3%
255.20
US$204,160 		800 -3.3% 255.20 US$204,160
2021-06-14 2021-06-10
US Repligen Corp (RGEN)
S Sale
6,802 -24.2%
189.19
US$1,286,870 		6,802 -24.2% 189.19 US$1,286,870
2021-05-18 2021-05-14
US Repligen Corp (RGEN)
S Sale
710 -2.8%
172.29
US$122,326 		710 -2.8% 172.29 US$122,326
2021-03-12 2021-03-10
US Repligen Corp (RGEN)
S Sale
1,004 -3.8%
192.13
US$192,899 		1,004 -3.8% 192.13 US$192,899
2021-03-12 2021-03-10
US Repligen Corp (RGEN)
S Sale
642 -2.4%
191.33
US$122,834 		642 -2.4% 191.33 US$122,834
2021-03-12 2021-03-10
US Repligen Corp (RGEN)
S Sale
6,354 -19.1%
190.08
US$1,207,768 		6,354 -19.1% 190.08 US$1,207,768
2021-03-08 2021-03-04
US Repligen Corp (RGEN)
S Sale
700 -2.7%
190.06
US$133,042 		700 -2.7% 190.06 US$133,042
2021-03-08 2021-03-04
US Repligen Corp (RGEN)
S Sale
600 -2.3%
191.20
US$114,720 		600 -2.3% 191.20 US$114,720
2021-03-08 2021-03-04
US Repligen Corp (RGEN)
S Sale
350 -1.3%
192.24
US$67,284 		350 -1.3% 192.24 US$67,284
2021-03-08 2021-03-04
US Repligen Corp (RGEN)
S Sale
25 -0.1%
194.30
US$4,858 		25 -0.1% 194.30 US$4,858
2021-03-08 2021-03-04
US Repligen Corp (RGEN)
S Sale
400 -1.5%
196.23
US$78,492 		400 -1.5% 196.23 US$78,492
2020-12-18 2020-12-16
US Repligen Corp (RGEN)
S Sale
435 -1.7%
186.18
US$80,988 		435 -1.7% 186.18 US$80,988
2020-08-10 2020-08-06
US Repligen Corp (RGEN)
S Sale
5,000 -16.1%
153.79
US$768,950 		5,000 -16.1% 153.79 US$768,950
2020-05-19 2020-05-15
US Repligen Corp (RGEN)
S Sale
435 -1.6%
140.69
US$61,200 		435 -1.6% 140.69 US$61,200
2020-05-15 2020-05-13
US Repligen Corp (RGEN)
S Sale
95 -0.4%
128.55
US$12,212 		95 -0.4% 128.55 US$12,212
2020-05-15 2020-05-13
US Repligen Corp (RGEN)
S Sale
6,293 -19.1%
128.02
US$805,630 		6,293 -19.1% 128.02 US$805,630
2020-05-15 2020-05-13
US Repligen Corp (RGEN)
S Sale
1,612 -4.7%
126.88
US$204,531 		1,612 -4.7% 126.88 US$204,531
2020-03-05 2020-03-04
US Repligen Corp (RGEN)
S Sale
1,905 -6.7%
90.99
US$173,336 		1,905 -6.7% 90.99 US$173,336
2020-03-05 2020-03-04
US Repligen Corp (RGEN)
S Sale
650 -2.2%
90.08
US$58,552 		650 -2.2% 90.08 US$58,552
2020-03-05 2020-03-03
US Repligen Corp (RGEN)
S Sale
450 -1.5%
88.35
US$39,758 		450 -1.5% 88.35 US$39,758
2020-02-27 2020-02-26
US Repligen Corp (RGEN)
S Sale
195 -0.7%
86.60
US$16,887 		195 -0.7% 86.60 US$16,887
2019-03-05 2019-03-05
US Repligen Corp (RGEN)
S Sale
2,240 -10.6%
58.53
US$131,107 		2,240 -10.6% 58.53 US$131,107
2019-03-04 2019-02-28
US Repligen Corp (RGEN)
S Sale
185 -1.1%
59.16
US$10,945 		185 -1.1% 59.16 US$10,945